| Literature DB >> 32718745 |
Hailey H Choi1, Shuchi K Rodgers2, David T Fetzer3, Ashish P Wasnik4, John D Millet4, Tara A Morgan5, Adrian Dawkins6, Helena Gabriel7, Aya Kamaya8.
Abstract
The Ultrasound Liver Imaging Reporting and Data System (US LI-RADS), introduced in 2017 by the American College of Radiology, standardizes the technique, interpretation, and reporting of screening and surveillance ultrasounds intended to detect hepatocellular carcinoma in high-risk patients. These include patients with cirrhosis of any cause as well as subsets of patients with chronic hepatitis B viral infection. The US LI-RADS scheme is composed of an ultrasound category and a visualization score: ultrasound categories define the exam as negative, subthreshold, or positive and direct next steps in management; visualization scores denote the expected sensitivity of the exam, based on adequacy of liver visualization with ultrasound. Since its introduction, multiple institutions across the United States have implemented US LI-RADS. This review includes a background of hepatocellular carcinoma and US LI-RADS, definition of screening/surveillance population, recommendations and tips for technique, interpretation, and reporting, and preliminary outcomes analysis. Published by Elsevier Inc.Entities:
Keywords: Hepatocellular carcinoma; Liver; Screening and surveillance; US LI-RADS; Ultrasound
Year: 2020 PMID: 32718745 DOI: 10.1016/j.acra.2020.06.004
Source DB: PubMed Journal: Acad Radiol ISSN: 1076-6332 Impact factor: 3.173